Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 2/20 | 0.43 |
| ▸ | CNR1 | P21554 | 2/20 | 0.43 |
| ▸ | CNR2 | P34972 | 2/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 7/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18804691 | 0.99 | SLC6A5 (0.45) | SLC6A5FAAHCNR1CNR2HRH3 | |
| SCHEMBL18804709 | 0.87 | SLC6A5 (0.46) | SLC6A5FAAHCNR1CNR2HRH3 | |
| SCHEMBL18804664 | 0.87 | SLC6A5 (0.46) | SLC6A5FAAHCNR1CNR2HRH3 | |
| SCHEMBL18804706 | 0.87 | SLC6A5 (0.46) | SLC6A5FAAHCNR1CNR2HRH3 | |
| SCHEMBL18804655 | 0.87 | SLC6A5 (0.46) | SLC6A5FAAHCNR1CNR2HRH3 | |
| SCHEMBL18804680 | 0.85 | CYP3A4 (0.44) | HRH3CYP3A4SLC7A5HRH4 | |
| SCHEMBL18804685 | 0.85 | CYP3A4 (0.44) | HRH3CYP3A4SLC7A5HRH4 | |
| SCHEMBL18804681 | 0.85 | CYP3A4 (0.44) | HRH3CYP3A4SLC7A5HRH4 | |
| SCHEMBL18804710 | 0.85 | CYP3A4 (0.44) | HRH3CYP3A4SLC7A5HRH4 | |
| SCHEMBL18804712 | 0.85 | CYP3A4 (0.44) | HRH3CYP3A4SLC7A5HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9795566-B2 | Imidazole compound and liposome containing same | FUJIFILM CORPORATION (JP) | 2017-10-24 | — | — | US | disclosed |
| US-20170119667-A1 | IMIDAZOLE COMPOUND AND LIPOSOME CONTAINING SAME | FUJIFILM CORPORATION (JP) | 2017-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119667-A1 | IMIDAZOLE COMPOUND AND LIPOSOME CONTAINING SAME | NPC1L1, LETM1, STOML2 | SLC6A5 2186/4885FAAH 1806/4885CNR1 1147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.